WordNet

dangerous to health; characterized by progressive and uncontrolled growth (especially of a tumor)
of or relating to the pleura or the walls of the thorax; "pleural muscles"
the thin serous membrane around the lungs and inner walls of the chest
a form of carcinoma of the mesothelium lining lungs or abdomen or heart; usually associated with exposure to asbestos dust

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 悪性胸膜中皮腫の臨床症状、診断、および病期分類 clinical presentation diagnosis and staging of malignant pleural mesothelioma
2. 限局性の悪性胸膜中皮腫および孤立性胸膜線維腫に対する治療アプローチ treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura
3. 悪性胸膜中皮腫の病理 pathology of malignant pleural mesothelioma
4. 切除不能悪性中皮腫に対する全身療法アプローチ systemic treatment approaches for unresectable malignant mesothelioma
5. 悪性腹膜中皮腫：治療 malignant peritoneal mesothelioma treatment

Remon J, Lianes P, Martínez S, Velasco M, Querol R, Zanui M.SourceMedical Oncology Department, Hospital de Mataró, Carretera de la Cirera, s/n, 08304 Mataró, Barcelona, Spain. Electronic address: jremon@csdm.cat.
Cancer treatment reviews.Cancer Treat Rev.2013 Oct;39(6):584-91. doi: 10.1016/j.ctrv.2012.12.005. Epub 2012 Dec 28.
Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy of the pleura associated with exposure to asbestos. Its incidence is anticipated to increase over the next 10years in both Europe and the developing nations. In advanced disease, chemotherapy is the cornerstone of treatment, es
PMID 23276688

Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma.

Kang Y, Ding M, Tian G, Guo H, Wan Y, Yao Z, Li B, Lin D.SourceDepartment of Respiratory Medicine, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.
Oncology reports.Oncol Rep.2013 Jul;30(1):313-9. doi: 10.3892/or.2013.2429. Epub 2013 Apr 26.
Malignant pleural mesothelioma (MPM) is a highly aggressive and conventional treatment-resistant tumor with a dismal prognosis. Among the three histological subtypes of MPM, the epithelioid is the most common type. Numb is considered as a tumor suppressor playing a critical role in controlling asymm
PMID 23624653

Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma.

Kao SC, van Zandwijk N, Corte P, Clarke C, Clarke S, Vardy J.SourceAsbestos Diseases Research Institute, Rhodes, Australia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.Support Care Cancer.2013 Jul;21(7):1879-84. doi: 10.1007/s00520-013-1753-3. Epub 2013 Feb 14.
PURPOSE: Malignant pleural mesothelioma (MPM) is considered a treatment-resistant disease. We determined the proportion of patients who received treatment in the last month of life and potential factors associated with use of chemotherapy at the end of life.METHODS: Consenting MPM patients compensat
PMID 23408016